S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

Cannae Stock Forecast, Price & News

-0.26 (-0.68 %)
(As of 03/5/2021 12:00 AM ET)
Today's Range
Now: $38.20
50-Day Range
MA: $39.95
52-Week Range
Now: $38.20
Volume2.07 million shs
Average Volume1.18 million shs
Market Capitalization$3.50 billion
P/E Ratio2.42
Dividend YieldN/A
Cannae Holdings, Inc. is a principal investment firm. The firm primarily invests in restaurants, technology enabled healthcare services, financial services and more. It takes both minority and majority stakes. Cannae Holdings, Inc. is based in Las Vegas, Nevada.
Cannae logo


New Strong Sell Stocks for March 4th - Yahoo Finance
March 4, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Eating & drinking places
Year FoundedN/A



Sales & Book Value

Annual Sales$1.07 billion
Cash Flow$2.76 per share
Book Value$21.23 per share


Net Income$77.30 million


Market Cap$3.50 billion
Next Earnings Date5/6/2021 (Estimated)


Overall MarketRank

1.71 out of 5 stars

Finance Sector

287th out of 1,942 stocks

Eating & Drinking Places Industry

3rd out of 18 stocks

Analyst Opinion: 2.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -
-0.26 (-0.68 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CNNE News and Ratings via Email

Sign-up to receive the latest news and ratings for CNNE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Cannae (NYSE:CNNE) Frequently Asked Questions

Is Cannae a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cannae in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cannae stock.
View analyst ratings for Cannae
or view top-rated stocks.

What stocks does MarketBeat like better than Cannae?

Wall Street analysts have given Cannae a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cannae wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cannae?

Cannae saw a drop in short interest in the month of February. As of February 12th, there was short interest totaling 1,210,000 shares, a drop of 20.4% from the January 28th total of 1,520,000 shares. Based on an average trading volume of 814,700 shares, the short-interest ratio is currently 1.5 days.
View Cannae's Short Interest

When is Cannae's next earnings date?

Cannae is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Cannae

How were Cannae's earnings last quarter?

Cannae Holdings, Inc. (NYSE:CNNE) announced its earnings results on Monday, February, 22nd. The company reported $5.80 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.09) by $5.89. The firm earned $170.40 million during the quarter, compared to analyst estimates of $179.35 million. Cannae had a trailing twelve-month return on equity of 52.16% and a net margin of 184.40%. The business's revenue for the quarter was down 38.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.66 EPS.
View Cannae's earnings history

How has Cannae's stock been impacted by COVID-19 (Coronavirus)?

Cannae's stock was trading at $31.27 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CNNE shares have increased by 22.2% and is now trading at $38.20.
View which stocks have been most impacted by COVID-19

What price target have analysts set for CNNE?

2 analysts have issued 1 year target prices for Cannae's stock. Their forecasts range from $43.00 to $52.00. On average, they expect Cannae's share price to reach $47.50 in the next year. This suggests a possible upside of 24.3% from the stock's current price.
View analysts' price targets for Cannae
or view top-rated stocks among Wall Street analysts.

Who are Cannae's key executives?

Cannae's management team includes the following people:
  • Mr. Richard Nelson Massey, CEO & Director (Age 65, Pay $85k)
  • Mr. David Ducommun, Pres (Age 44, Pay $1.12M)
  • Mr. Michael Louis Gravelle, Exec. VP, Gen. Counsel & Corp. Sec. (Age 59, Pay $1.1M)
  • Mr. Bryan D. Coy, CFO & Principal Accounting Officer (Age 50)
  • Mr. Ryan R. Caswell, Sr. VP of Corp. Fin. (Age 38)

Who are some of Cannae's key competitors?

What other stocks do shareholders of Cannae own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cannae investors own include NVIDIA (NVDA), General Motors (GM), Advanced Micro Devices (AMD), Enphase Energy (ENPH), Pure Storage (PSTG), QUALCOMM (QCOM), Square (SQ), Twilio (TWLO), Vista Outdoor (VSTO) and Zynga (ZNGA).

What is Cannae's stock symbol?

Cannae trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNNE."

Who are Cannae's major shareholders?

Cannae's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (7.20%), Principal Financial Group Inc. (1.87%), Principal Financial Group Inc. (1.86%), Dimensional Fund Advisors LP (1.44%), Northern Trust Corp (1.40%) and Confluence Investment Management LLC (1.00%). Company insiders that own Cannae stock include Brent B Bickett, Frank P Willey, Michael L Gravelle, Richard L Cox and Richard N Massey.
View institutional ownership trends for Cannae

Which institutional investors are selling Cannae stock?

CNNE stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Azora Capital LP, The Manufacturers Life Insurance Company , Great Lakes Advisors LLC, Assenagon Asset Management S.A., Dimensional Fund Advisors LP, Russell Investments Group Ltd., and Verition Fund Management LLC.
View insider buying and selling activity for Cannae
or view top insider-selling stocks.

Which institutional investors are buying Cannae stock?

CNNE stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, Principal Financial Group Inc., Principal Financial Group Inc., BlackRock Inc., Waratah Capital Advisors Ltd., Canada Pension Plan Investment Board, Epoch Investment Partners Inc., and Full18 Capital LLC. Company insiders that have bought Cannae stock in the last two years include Brent B Bickett, Frank P Willey, Michael L Gravelle, Richard L Cox, and Richard N Massey.
View insider buying and selling activity for Cannae
or or view top insider-buying stocks.

How do I buy shares of Cannae?

Shares of CNNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cannae's stock price today?

One share of CNNE stock can currently be purchased for approximately $38.20.

How much money does Cannae make?

Cannae has a market capitalization of $3.50 billion and generates $1.07 billion in revenue each year. The company earns $77.30 million in net income (profit) each year or $1.76 on an earnings per share basis.

How many employees does Cannae have?

Cannae employs 22,482 workers across the globe.

What is Cannae's official website?

The official website for Cannae is www.cannaeholdings.com.

Where are Cannae's headquarters?

Cannae is headquartered at 1701 VILLAGE CENTER CIRCLE, LAS VEGAS NV, 89134.

How can I contact Cannae?

Cannae's mailing address is 1701 VILLAGE CENTER CIRCLE, LAS VEGAS NV, 89134. The company can be reached via phone at 702-323-7330.

This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.